Clinical Trial Update: A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke) [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of CNTO 0007 (42037788) versus placebo in patients with ischemic stroke/ischaemic cerebral infarction; the trial has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia
• Ischemic Cerebral Infarction
• Stroke

Drugs mentioned

• CNTO 0007

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Stroke, Ischemia | Phase 1 | Status: COMPLETED